The American Society of Hematology (ASH) and the International Society on Thrombosis and Haemostasis (ISTH) released new and updated clinical practice guidelines for the treatment of pediatric venous ...
Besremi is now a Category 1 preferred treatment for high-risk ET patients with inadequate response to existing therapies, according to NCCN guidelines. The NCCN's inclusion of Besremi reflects strong ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that the National ...
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) regarding characterization and treatment of central nervous system (CNS) cancers were very recently updated and have expanded the ...
ROSEMONT, IL, UNITED STATES, March 24, 2026 /EINPresswire.com/ — The Society for Vascular Surgery (SVS) has released an updated clinical practice guideline on the ...
SAN DIEGO & ST. GALLEN, Switzerland--(BUSINESS WIRE)--CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice guidelines for the ...